{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:15:21Z","timestamp":1786986921112,"version":"build-2736575974"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.clinbiochem.2019.11.010","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T21:15:13Z","timestamp":1575407713000},"page":"38-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The challenge that chlorine presented during the development of a benzodiazepine assay"],"prefix":"10.1016","volume":"76","author":[{"given":"Richard G.","family":"Lahr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Jannetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loralie J.","family":"Langman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2019.11.010_b0005","series-title":"Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e","article-title":"Chapter 19 hypnotics and sedatives","author":"Mihic","year":"2017"},{"key":"10.1016\/j.clinbiochem.2019.11.010_b0010","series-title":"Principles of Forensic Toxicology","first-page":"237","article-title":"Chapter 14: benzodiazepines","author":"Jufer-Phipps","year":"2017"},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.11.010_b0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1373\/jalm.2017.023341","article-title":"Executive summary: american association of clinical chemistry laboratory medicine practice guideline\u2014Using clinical laboratory tests to monitor drug therapy in pain management patients","volume":"2","author":"Jannetto","year":"2018","journal-title":"J. Appl. Labor. Med.: AACC Publ."},{"issue":"9","key":"10.1016\/j.clinbiochem.2019.11.010_b0020","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s11606-016-3740-0","article-title":"Benzodiazepines are prescribed more frequently to patients already at risk for benzodiazepine-related adverse events in primary care","volume":"31","author":"Kroll","year":"2016","journal-title":"J. Gen. Intern. Med."},{"issue":"6","key":"10.1016\/j.clinbiochem.2019.11.010_b0025","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/pds.3951","article-title":"Trends in prescribing of sedative-hypnotic medications in the USA: 1993\u20132010","volume":"25","author":"Kaufmann","year":"2016","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.clinbiochem.2019.11.010_b0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.talanta.2011.09.063","article-title":"Expanding the linear dynamic range for multiple reaction monitoring in quantitative liquid chromatography\u2013tandem mass spectrometry utilizing natural isotopologue transitions","volume":"87","author":"Hanghui Liu","year":"2011","journal-title":"Talanta"},{"issue":"10","key":"10.1016\/j.clinbiochem.2019.11.010_b0035","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/dta.2175","article-title":"Increasing the linear dynamic range in LC-MS: is it valid to use a less abundant isotopologue?","volume":"9","author":"Trobbiani","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.clinbiochem.2019.11.010_b0040","doi-asserted-by":"crossref","unstructured":"A.L.R. Geoffrey S. Rule, and Kamisha L. Johnson-Davis, LC-MS\/MS Method for the Quantification of the Leflunomide Metabolite, Teriflunomide, in Human Serum\/Plasma, LC-MS in Drug Analysis: Methods and Protocols 1872 (2019) 75\u201383.","DOI":"10.1007\/978-1-4939-8823-5_8"},{"issue":"10","key":"10.1016\/j.clinbiochem.2019.11.010_b0045","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jasms.2004.04.034","article-title":"Charge competition and the linear dynamic range of detection in electrospray ionization mass spectrometry","volume":"15","author":"Tang","year":"2004","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.11.010_b0050","first-page":"1","article-title":"Enhancement and suppression of ionization in drug analysis using HPLC-MS\/MS in support of therapeutic drug monitoring: a review of current knowledge of its minimization and assessment","volume":"40","author":"George","year":"2018","journal-title":"Ther. Drug Monit."},{"issue":"15","key":"10.1016\/j.clinbiochem.2019.11.010_b0055","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.1021\/acs.analchem.9b00947","article-title":"Development, validation, and application of a new method to correct the nonlinearity problem in LC-MS\/MS quantification using stable isotope-labeled internal standards","volume":"91","author":"Liu","year":"2019","journal-title":"Anal. Chem."},{"issue":"8","key":"10.1016\/j.clinbiochem.2019.11.010_b0060","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1351\/PAC-REP-09-06-03_errata","article-title":"Atomic weights of the elements","volume":"81","author":"de Laeter","year":"2009","journal-title":"Pure Appl. Chem."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912019309221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912019309221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:55:03Z","timestamp":1757865303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912019309221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":12,"alternative-id":["S0009912019309221"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.11.010","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The challenge that chlorine presented during the development of a benzodiazepine assay","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}]}}